Keywords: 3-MP; 3-mercaptopyruvate; 3-MST; 3-mercaptopyruvate sulfurtransferase; AAT; aspartate amino transferase; AE1; anion exchanger-1; AGEs; advanced glycation end products; AKI; acute kidney injury; AMPK; AMP-activated protein kinase; AT1; angiotensin receptor
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Glu; l-glutamic acid monosodium salt monohydrate; DMSO; dimethyl sulphoxide; mEPSP; miniature excitatory postsynaptic potential; ICa; calcium current; IKD; delayed potassium current; PKA; protein kinase A; ER; endoplasmic reticulum; LY341495; (2S)-2-amino
Keywords: AGAP; anti-tumor analgesic peptide; AMPA; α-amino-3-hydroxy-5methylisoxazole-4-propionic acid; ASICs; acid-sensitive ion channels; ATP; adenosine triphosphate; Bmk; toxin isolated from Chinese scorpion Mesobuthus martensii (previously Buthus martensii Ka
Keywords: AMPA; α-amino-3-hydroxy-5-methyl-4- isoxazole propionic acid; ASI; Axon-spine interface; Ca2+; calcium; CNS; Central nervous system; CS-EP; Corticostriatal-evoked potential; DBS; deep brain stimulation; DA; Dopamine; DARPP-32; dopamine-regulated neuronal
Keywords: ASPS; advanced sleep phase syndrome; AUD; alcohol use disorder; BDZ; benzodiazepine; CK1; casein kinase 1; CD; circadian desynchrony; CRSDs; circadian rhythm sleep disorders; DSPS; delayed sleep phase disorder; DA; dopamine; DARPP32; dopamine- and cAMP-re
Keywords: Opioids; Analgesia; Adverse effects; Mechanisms; Constipation; Nausea; Vomiting; Respiratory depression; 5-HT; 5-hydroxytryptamine; 7TMRs; 7-transmembrane spanning G-protein coupled receptors; AC; adenylyl cyclase; β-arr1; β-arrestin1; β-arr2; β-arres
Keywords: BBB; Blood-brain-barrier; CNS; central nervous system; GI; gastrointestinal; GWAS; genome wide association studies; HLA; Human leukocyte antigen; MHC; Major histocompatibility complex; NMDA; N-methyl-d-aspartate; SCFAs; Small chain fatty acids; Autoantige
Keywords: Nitrosylation; Neuroprogression; Neurotrophin; Neurogenesis; Apoptosis; NMDA; mTOR; Psychiatry; Neurology;
Keywords: Neural circuits; Reinstatement; Self-administration; Ventral pallidum; Voluntary abstinence; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; BLA; basolateral amygdala; BNST; bed nucleus of the stria terminalis; CeA; central amygdala nucleus;
Keywords: AC; adenylate cyclase; ADHD; attention deficit hyperactivity disorder; ACC; anterior cingulate cortex; ALS; amyotrophic lateral sclerosis; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ATP; adenosine triphosphate; BBB; blood-brain barrier;
Keywords: AA; amino acid; Aβo; oligomeric β-amyloid; Aβ; β-amyloid; AD; Alzheimer's disease; α7nAChR; α7 nicotinic acetylcholine receptor; ALS; amyotrophic lateral sclerosis; APLP1; amyloid beta precursor-like protein 1; APP; amyloid precursor protein; β-A
Keywords: ACTH; adrenocorticotropic hormone; AChR; acetylcholine receptor; ALS; amyotrophic lateral sclerosis; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; Ca2+; a calcium ion; CA1; cornu ammonis area 1, a region in the hippocampus anatomy; CO2; car
Keywords: AUD; Alcohol use disorder; FDA; Food and Drug Administration; MOR; Mu opioid receptor; DOR; Delta opioid receptor; KOR; Kappa opioid receptor; NMDA; N-methyl-d-aspartate; GABA; Gaba amino butyric acid; DSM-IV; Diagnostic and statistical measurement IV; PA
Keywords: 5-HT; 5-hydroxytryptamine; AA; arachidonic acid; ACh; acetylcholine; ACTH; adrenocorticotrophic hormone; AD; Alzheimer's Disease; ADP; adenosine diphosphate; Aβ; amyloid β; AMP; adenosine monophosphate; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepro
Keywords: Donepezil-flavonoid hybrids; Neurogenesis; Neuroprotection; Sigma receptors; Human acetylcholinesterase; Human 5-lipoxygenase; Human monoamine oxidases; AChE; acetylcholinesterase; AD; Alzheimer's disease; ATCh; acetylthiocholine; BBB; blood-brain barrier
Keywords: ACh; Acetylcholine; A-P; Anterior-posterior; AChE; Acetylcholinesterase; AD; Alzheimer's disease; Akt; Serine/threonine kinase; ALA; Aplpha linoleic acid; AM; Amygdala; AMPA; α-Amino- 3-hydroxy-5-methyl-4-isoxazolepropionic acid; AP-7; 2-amino-7-phosph
Keywords: ALS; Amyotrophic lateral sclerosis; DMD; DuchenneMuscular Dystrophy; SMA; Spinalmuscular atrophy; FAP; FamilialAmyloid Polyneuropathy; OD; Orphandisease; ORD; Officeof Rare Diseases; NIH; NationalInstitutes of Health; sALS; SporadicALS; fALS; FamilialALS;
Keywords: AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; α-SMA; alpha- smooth muscle actin; BBB; blood-brain barrier; BDNF; brain derived neurotrophic factor; bFGF or FGF2; basic fibroblast growth factor; BrdU; bromodeoxyuridine; CIMT; const
Keywords: AR; antidepressant response; NMDA; N-methyl-d-aspartat; mTORC1; mechanistic target of rampamycin complex 1; BDNF; brain-derived neurotrophic factor; NGF; nerve growth factor; GABA; gamma-amino-butyric acid; Na; natrium; Ca; calcium; Ketamine; Ethanol; Ant
Keywords: Cone snails; Conopeptides; Contryphans; Short conopeptides; Linear peptides; Mass spectrometry; NMDA; N-methyl-d-aspartate; TCEP; Tris (2-carboxyethyl) phosphine (Pierce Scientific, United States); NEM; N-Methylmaleimide (Sigma-Aldrich, United States); CC
Keywords: Cathepsin S; Social behavior abnormality; Microglia; Synaptic activity; ACSF; artificial cerebrospinal fluid; ANOVA; one-way analysis of variance; CatS; cathepsin S; CysC; cystatin C; ECM; extracellular matrix; EPSCs; excitatory postsynaptic currents; LPS
Keywords: Arc; activity regulated cytoskeleton associated protein; Arp2; actin related protein 2; Cdc42; cell division control protein 42; IRSp53/58; insulin receptor substrate protein 53/58; NMDA; N-methyl-d-aspartate; RT-PCR; real time - polymerase chain reacti
Keywords: BP; blood pressure; EEG; electroencephalography; HR; heart rate; IV; intravenous; NMDA; N-methyl-d-aspartate; RASS; Richmond Agitation-Sedation Scale; RR; respiratory rate; Spo2; arterial oxyhemoglobin saturation;
Keywords: POCD; postoperative cognitive dysfunction; RGS; grimace scale; POD; postoperative day; NMDA; N-methyl-D-aspartate; TNF-α; tumor necrosis factor-α; IL; interleukin; postoperative cognitive dysfunction (POCD); thalidomide; pain; NMDA receptors; inflammati
Keywords: Hippocampus; Cytokines; Inflammation; Epilepsy; Activated microglia; ASD; Anti-Seizure Drug; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ATP; Adenosine Triphosphate; DAMP; Danger Associated Molecular Pattern; FS; Febrile Seizures; GABA; G
Keywords: IL-1B; interlukins 1-beta; LPS; lipopolysaccharide; ICE; IL-1β converting enzyme; TLE; temporal lobe epilepsy; BBB; blood brain barrier; NMDA; N-methyl-d-aspartate; IL-1R1; interlukin-1 receptor, type 1; TNF-alpha; tumor necrosis factor- alpha; PTZ; pent
Keywords: ANOVA; analysis of variance; CNS; central nervous system; Egr-1; early growth response-1; GABA; gamma-aminobutyric acid; NMDA; N-methyl-d-aspartate; OD; optical density; Behavioral sensitization; Ethanol; Egr-1; NMDA receptor; Cocaine;
Keywords: PTSD; post-traumatic stress disorder; SPS; single prolonged stress; PND; post-natal day; LD; light and dark test; EPM; elevated plus maze test; STM; short term memory; LTM; long term memory; FST; forced swim test; NMDA; N-methyl-d-aspartate; BDNF; brain-d
Keywords: BDNF; brain-derived neurotrophic factor; CNS; central nervous system; CPP; conditioned place preference; DA; dopamine; DDC; dopa decarboxylase; GABA; gamma-aminobutyric acid; NAc; nucleus accumbens; NMDA; N-methyl-d-aspartate; PFC; prefrontal cortex; qRT-
Keywords: FP; field potential; GABA; γ-aminobutyric acid; LTP; long-term potentiation; LTD; long-term depression; NMDA; N-methyl-d-aspartate; PD; postnatal day; ACSF; artificial cerebrospinal fluid; DL-APV; DL-2-amino-5-phosphonovaleric acid; TNFα; tumor necrosis
Keywords: Autism; Pathophysiology; Neurons; Models; Cav; L-type voltage-gated calcium channel; NMDA; N-methyl-D-aspartate receptor; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; mGluR; metabotropic glutamate receptor; CaMKII; Ca2+/calmodulin
Keywords: ADHD; Attention deficit/hyperactivity disorder; CDC; Centers for Disease Control and Prevention; CHAMACOS; Center for the Health Assessment of Mothers and Children of Salinas; GM; Geometric mean; HOME Study; Health Outcomes and Measures of the Environment
Keywords: 5-HT; serotonin; DA; dopamine; GABA; γ-aminobutyric acid; LHb; lateral habenula; mPFC; medial prefrontal cortex; NMDA; N-methyl-d-aspartate; cognitive flexibility; behavioral flexibility; reversal learning; habenula; set-shifting; reward prediction error
Keywords: ACSF; artificial cerebrospinal fluid; CA1; cornu ammonis area 1; CA3; cornu ammonis area 3; DG; dentate gyrus; EC; entorhinal cortex; fEPSP(s); field excitatory postsynaptic potential(s); GABA; gamma aminobutyric acid; NMDA; N-methyl D-aspartate; SE; stat
Keywords: AP5; 2-amino-5-phosphonopentoic acid; AUC; area under the curve; BMI; bicuculline methiodide; DE; dry eye; GABA; gamma-aminobutyric acid; HS; hypertonic saline; MAP; mean arterial pressure; NMDA; N-methyl-D-aspartate; OOemg; orbicularis oculi muscle elect
Keywords: ACC; anterior cingulate cortex; ATP; adenosine triphosphate; CB; cannabinoid receptor; CD; Chron's disease; CGRP; calcitonin-gene related peptide; CNS; central nervous system; CRF; corticotropin releasing factor; ECC; enterochromaffin cell; ENS; enteric n
Keywords: AED; antiepileptic drug; ATL; anterior temporal lobectomy; CBD; cannabidiol; DBS; deep brain stimulation; ECoG; electrocorticography; FDA; Food and Drug Administration; GABA; γ-aminobutyric acid; LiTT; laser interstitial thermal therapy; MRI; magnetic re
Keywords: Psychiatry; Depression; Treatment; NMDA; ECT; electroconvulsive therapy; CI; confidence interval; MA; meta-analysis; Tx; treatment; No.; number; EEG; electroencephalogram; NMDA; N-methyl-d-aspartate; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
Keywords: AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; DRG; dorsal root ganglia; ([Ca2+]i); intracellular Ca2+ concentration; KA; kainic acid; MD; Minamata Disease; MeHg; methylmercury; MN; motor neuron; NMDA; N-methyl-d-aspartate; SOD1; superoxide
Keywords: Kainate receptors; N-terminal domain; Ligand-binding domain; Crystal structures; Ligands; Mutations; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate; iGluRs; ionotropic glutamate receptors; LBDs; ligand-binding domains; NMDA; N-methyl-d-aspartate;
Keywords: Schizophrenia; Systems pharmacology; Drug treatment; PANSS Total; Combination therapy; Information bandwidth; CNS; Central Nervous Systems; DA; Dopamine; GPCR; G-Protein coupled receptor; GPe; Globus Pallidus Externa; GPi; Globus Pallidus interna; MSN; Me
Keywords: APV; dl-2-amino-5-phosphonovaleric acid; CNQX; 6-cyano-7-nitroquinoxaline-2,3-dione; DMNV; dorsal motor nucleus of the vagus nerve; E; embryonic day (days of incubation in avians and days of pregnancy in mammals); EPSP; excitatory postsynaptic potential;
Keywords: ADC; arginine decarboxylase; CN; cued navigation; DG; dentate gyrus; FST; forced swim test; GABA; γ-aminobutyric acid; HPLC; high performance liquid chromatography; LC/MS; liquid chromatography/mass spectrometry; NMDA; N-methyl-d-aspartate; NO; nitric ox
Keywords: psychosis; consciousness; subliminal; top-down; dysconnectivity; NMDA;
Keywords: AE; adverse event; CDSR; Cochrane Database of Systematic Reviews; COMTI; catechol-O-methyltransferase inhibitor; DOPA; dopamine; FDA; Food and Drug Administration; GABA; γ-aminobutyric acid; GnRH; gonadotropin-releasing hormone; IQR; interquartile range;
Glutathione in the human brain: Review of its roles and measurement by magnetic resonance spectroscopy
Keywords: Glutathione; Magnetic resonance spectroscopy; Brain; Glyoxalase; Psychiatric disease; Neurological disease; GSH; glutathione; GSSG; oxidized glutathione; NMDA; N-methyl-D-aspartate; GCL; glutamate-cysteine ligase; GCLC; glutamate-cysteine ligase subunit w
Keywords: CGRP; calcitonin gene related peptide; CSD; cortical spreading depression; NSAIDs; non-steroidal anti-inflammatory drugs; 5-HT; 5-hydroxytryptamine; 5-HIAA; 5-hydroxyindoleacetic acid; NO; nitric oxide (NO); TG; trigeminal ganglion; TNC; trigeminal nucleu
Keywords: 3-HK; 3-hydroxykynurenine; 6-OHDA; 6-hydroxydopamine; A; Amygdala; ACMSD; 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase; AD; Alzheimer's disease; AD; Anterodorsal nucleus (Thalamus); α-syn; Alpha-synuclein; CCL2; Chemokine (CC motif) ligand 2;
Keywords: Dopamine; Ecstasy; Methamphetamine; METH; 3,4-Methylenedioxymethamphetamine; MDMA; Mouse; Neurodegeneration; Neuroinflammation neurotoxicity; Non-human primate; Rat; AC; adenylyl cyclase; AcbSh; nucleus accumbens shell; AcbC; nucleus accumbens core; cAMP;
Keywords: Estrogen; Neuroprotection; Aging; Cognition; Stroke; Traumatic brain injury; 3NPA; 3-nitropropionic acid; 17αE2; 17 alpha-estradiol; 17βE2; 17 beta-estradiol; ATP; adenosine triphosphate; BBB; blood brain barrier; BDNF; brain-derived neurotrophic factor